| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.59 | 0.04 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.49 | 0.09 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.46 | 0.1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.44 | 0.01 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.27 | 0.07 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.2 | 0.0004 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0008 |